Effect of race-free estimated glomerular filtration rate equations (eGFR) on oncology clinical trial eligibility for Black patients.

ELRIG, a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D ...

Membership in the American Society of Clinical Oncology and Association for Clinical Oncology (collectively, ASCO) connects you to a multidisciplinary, global network of more than 50,000 oncology ...

Cancer Research & Oncology 2025 will offer a 1-day content-rich program providing invited lectures, thought-provoking discussions and posters to explore global developments and advancements in the ...

Mia Love, the first Black Republican woman elected to Congress, died three years after being diagnosed with glioblastoma, a ...

Labroots is pleased to announce the 5th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking research in ...

Updated clinical & translational results: BOND-003 Cohort C- A phase 3, single-arm study of intravesical cretostimogene grenadenorepvec for high-risk BCG-unresponsive non-muscle invasive bladder ...

Anemia and low performance status predict worse survival and greater risk for treatment failure in low-intermediate risk vs ...

VAIL, CO USA (UroToday.com) - Presented by E. Francisco G. La Rosa, MD, Cliff Jones, DDS, Paul Arangua, E. David Crawford, MD, and Leander Van Neste, PhD at the 24th International Prostate Cancer ...

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.